In the present study, our aim was to investigate the serum levels of IL-18 and NO and serum levels of the total oxidative and anti-oxidative capacity (TOC and TAC) in cancer breast patients either newly diagnosed or metastatic cases in comparison to patients with benign breast tumours in order to add more knowledge to their possible role in these patients groups. Here, IL18 is linked to breast benign neoplasm.